IDEX CORP /DE/ - Quarter Report: 2009 September (Form 10-Q)
Table of Contents
UNITED STATES SECURITIES AND
EXCHANGE COMMISSION
Washington, D.C.
20549
FORM 10-Q
þ
|
QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 | |
For the quarterly period ended September 30, 2009 | ||
OR
|
||
o
|
TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 |
Commission file number 1-10235
IDEX CORPORATION
(Exact Name of Registrant as
Specified in its Charter)
Delaware | 36-3555336 | |
(State or other jurisdiction
of incorporation or organization) |
(I.R.S. Employer Identification No.) |
|
630 Dundee Road, Northbrook, Illinois (Address of principal executive offices) |
60062 (Zip Code) |
Registrants telephone number: (847) 498-7070
Indicate by check mark whether the registrant: (1) has
filed all reports required to be filed by Section 13 or
15(d) of the Securities Exchange Act of 1934 during the
preceding 12 months (or for such shorter period that the
registrant was required to file such reports), and (2) has
been subject to such filing requirements for the past
90 days.
Yes þ No o
Indicate by check mark whether the registrant has submitted
electronically and posted on its corporate Web site, if any,
every Interactive Data File required to be submitted and posted
pursuant to Rule 405 of Regulation S-T during the
preceding 12 months (or for such shorter period that the
registrant was required to submit and post such files).
Yes o No o
Indicate by check mark whether the registrant is a large
accelerated filer, an accelerated filer, a non-accelerated
filer, or a smaller reporting company. See the definitions of
large accelerated filer, accelerated
filer and smaller reporting company in
Rule 12b-2 of the Exchange Act. (Check one):
Large accelerated filer þ | Accelerated filer o | Non-accelerated filer o | Smaller reporting company o |
(Do not check if a smaller reporting company)
Indicate by check mark whether the registrant is a shell company
(as defined in Rule 12b-2 of the Exchange Act).
Yes o No þ
Number of shares of common stock of IDEX Corporation outstanding
as of October 30, 2009: 80,827,210 (net of treasury shares).
TABLE OF
CONTENTS
Table of Contents
PART I.
FINANCIAL INFORMATION
Item 1. | Financial Statements. |
IDEX
CORPORATION AND SUBSIDIARIES
CONDENSED CONSOLIDATED BALANCE SHEETS
(in thousands except share and per share amounts)
(unaudited)
CONDENSED CONSOLIDATED BALANCE SHEETS
(in thousands except share and per share amounts)
(unaudited)
September 30, 2009 | December 31, 2008_ | |||||||
ASSETS
|
||||||||
Current assets
|
||||||||
Cash and cash equivalents
|
$ | 74,429 | $ | 61,353 | ||||
Receivables, less allowance for doubtful accounts of $6,798 at
September 30, 2009 and $5,600 at December 31, 2008
|
189,417 | 205,269 | ||||||
Inventories
|
162,384 | 181,200 | ||||||
Other current assets
|
32,363 | 32,866 | ||||||
Total current assets
|
458,593 | 480,688 | ||||||
Property, plant and equipment net
|
181,006 | 186,283 | ||||||
Goodwill
|
1,186,156 | 1,167,063 | ||||||
Intangible assets net
|
288,396 | 303,226 | ||||||
Other noncurrent assets
|
8,692 | 14,540 | ||||||
Total assets
|
$ | 2,122,843 | $ | 2,151,800 | ||||
LIABILITIES AND SHAREHOLDERS EQUITY | ||||||||
Current liabilities
|
||||||||
Trade accounts payable
|
$ | 76,321 | $ | 87,304 | ||||
Accrued expenses
|
114,676 | 117,186 | ||||||
Short-term borrowings
|
6,307 | 5,856 | ||||||
Dividends payable
|
9,554 | 9,523 | ||||||
Total current liabilities
|
206,858 | 219,869 | ||||||
Long-term borrowings
|
440,832 | 548,144 | ||||||
Deferred income taxes
|
146,857 | 141,984 | ||||||
Other noncurrent liabilities
|
91,920 | 97,020 | ||||||
Total liabilities
|
886,467 | 1,007,017 | ||||||
Commitment and contingencies
|
||||||||
Shareholders equity
|
||||||||
Preferred stock:
|
||||||||
Authorized: 5,000,000 shares, $.01 per share par value;
Issued: None
|
| | ||||||
Common stock:
|
||||||||
Authorized: 150,000,000 shares, $.01 per share par value
|
||||||||
Issued: 83,277,330 shares at September 30, 2009 and
82,786,045 shares at December 31, 2008
|
833 | 828 | ||||||
Additional paid-in capital
|
393,832 | 377,154 | ||||||
Retained earnings
|
873,590 | 822,286 | ||||||
Treasury stock at cost: 2,537,538 shares at
September 30, 2009 and 2,483,955 shares at
December 31, 2008
|
(56,597 | ) | (55,393 | ) | ||||
Accumulated other comprehensive income (loss)
|
24,718 | (92 | ) | |||||
Total shareholders equity
|
1,236,376 | 1,144,783 | ||||||
Total liabilities and shareholders equity
|
$ | 2,122,843 | $ | 2,151,800 | ||||
See Notes to Condensed Consolidated Financial Statements.
1
Table of Contents
IDEX
CORPORATION AND SUBSIDIARIES
CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS
(in thousands except per share amounts)
(unaudited)
CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS
(in thousands except per share amounts)
(unaudited)
Three Months Ended |
Nine Months Ended |
|||||||||||||||
September 30, | September 30, | |||||||||||||||
2009 | 2008 | 2009 | 2008 | |||||||||||||
Net sales
|
$ | 323,249 | $ | 365,193 | $ | 986,317 | $ | 1,134,165 | ||||||||
Cost of sales
|
194,191 | 217,409 | 602,964 | 672,391 | ||||||||||||
Gross profit
|
129,058 | 147,784 | 383,353 | 461,774 | ||||||||||||
Selling, general and administrative expenses
|
79,789 | 81,614 | 242,687 | 258,082 | ||||||||||||
Goodwill impairment
|
| 30,090 | | 30,090 | ||||||||||||
Restructuring expenses
|
2,752 | 5,276 | 8,253 | 5,276 | ||||||||||||
Operating income
|
46,517 | 30,804 | 132,413 | 168,326 | ||||||||||||
Other income net
|
1,382 | 2,723 | 806 | 3,885 | ||||||||||||
Interest expense
|
3,951 | 3,861 | 13,212 | 13,619 | ||||||||||||
Income before income taxes
|
43,948 | 29,666 | 120,007 | 158,592 | ||||||||||||
Provision for income taxes
|
14,171 | 9,783 | 39,703 | 54,046 | ||||||||||||
Net income
|
$ | 29,777 | $ | 19,883 | $ | 80,304 | $ | 104,546 | ||||||||
Basic earnings per common share
|
$ | 0.37 | $ | 0.24 | $ | 1.00 | $ | 1.27 | ||||||||
Diluted earnings per common share
|
$ | 0.37 | $ | 0.24 | $ | 0.99 | $ | 1.26 | ||||||||
Share data:
|
||||||||||||||||
Basic weighted average common shares outstanding
|
79,740 | 81,572 | 79,642 | 81,320 | ||||||||||||
Diluted weighted average common shares outstanding
|
80,879 | 82,957 | 80,535 | 82,663 |
See Notes to Condensed Consolidated Financial Statements.
2
Table of Contents
IDEX
CORPORATION AND SUBSIDIARIES
CONDENSED CONSOLIDATED STATEMENTS OF SHAREHOLDERS EQUITY
(in thousands except share and per share amounts)
(unaudited)
CONDENSED CONSOLIDATED STATEMENTS OF SHAREHOLDERS EQUITY
(in thousands except share and per share amounts)
(unaudited)
Accumulated Other Comprehensive Income (Loss) | ||||||||||||||||||||||||||||
Net |
||||||||||||||||||||||||||||
Actuarial |
||||||||||||||||||||||||||||
Losses |
||||||||||||||||||||||||||||
and Prior |
||||||||||||||||||||||||||||
Service |
||||||||||||||||||||||||||||
Costs on |
||||||||||||||||||||||||||||
Pensions |
Cumulative |
|||||||||||||||||||||||||||
and Other |
Unrealized |
|||||||||||||||||||||||||||
Common Stock |
Post- |
Losses |
||||||||||||||||||||||||||
and Additional |
Cumulative |
Retirement |
on Derivatives |
Total |
||||||||||||||||||||||||
Paid-In |
Retained |
Translation |
Benefit |
Designated as Cash |
Treasury |
Shareholders |
||||||||||||||||||||||
Capital | Earnings | Adjustment | Plans | Flow Hedges | Stock | Equity | ||||||||||||||||||||||
Balance, December 31, 2008, as previously stated
|
$ | 377,982 | $ | 845,396 | $ | 39,873 | $ | (33,654 | ) | $ | (6,642 | ) | $ | (55,393 | ) | $ | 1,167,562 | |||||||||||
Impact of adopting change in accounting related to inventory
(see Note 5)
|
| (23,110 | ) | 331 | | | | (22,779 | ) | |||||||||||||||||||
Balance, December 31, 2008, as restated
|
$ | 377,982 | $ | 822,286 | $ | 40,204 | $ | (33,654 | ) | $ | (6,642 | ) | $ | (55,393 | ) | $ | 1,144,783 | |||||||||||
Net income
|
| 80,304 | | | | | 80,304 | |||||||||||||||||||||
Other comprehensive income, net of tax:
|
||||||||||||||||||||||||||||
Cumulative translation adjustment
|
| | 23,558 | | | | 23,558 | |||||||||||||||||||||
Amortization of retirement obligations
|
| | | 1,702 | | | 1,702 | |||||||||||||||||||||
Unrealized gain on derivatives designated as cash flow hedges
|
| | | | (450 | ) | | (450 | ) | |||||||||||||||||||
Other comprehensive income
|
| | | | | | 24,810 | |||||||||||||||||||||
Comprehensive income
|
| | | | | | 105,114 | |||||||||||||||||||||
Issuance of 238,388 shares of common stock from exercise of
stock options and deferred compensation plans, net of tax benefit
|
3,902 | | | | | | 3,902 | |||||||||||||||||||||
Share-based compensation
|
12,781 | | | | | | 12,781 | |||||||||||||||||||||
Unvested shares surrendered for tax withholding
|
| | | | | (1,204 | ) | (1,204 | ) | |||||||||||||||||||
Cash dividends declared $.36 per common share
|
| (29,000 | ) | | | | | (29,000 | ) | |||||||||||||||||||
Balance, September 30, 2009
|
$ | 394,665 | $ | 873,590 | $ | 63,762 | $ | (31,952 | ) | $ | (7,092 | ) | $ | (56,597 | ) | $ | 1,236,376 | |||||||||||
See Notes to Condensed Consolidated Financial Statements.
3
Table of Contents
IDEX
CORPORATION AND SUBSIDIARIES
CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS
(in thousands)
(unaudited)
CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS
(in thousands)
(unaudited)
Nine Months |
||||||||
Ended |
||||||||
September 30, | ||||||||
2009 | 2008 | |||||||
Cash flows from operating activities
|
||||||||
Net income
|
$ | 80,304 | $ | 104,546 | ||||
Adjustments to reconcile net income to net cash provided by
operating activities:
|
||||||||
Loss on sale of fixed assets
|
447 | | ||||||
Goodwill impairment
|
| 30,090 | ||||||
Depreciation and amortization
|
23,482 | 23,468 | ||||||
Amortization of intangible assets
|
18,411 | 11,624 | ||||||
Amortization of debt issuance expenses
|
232 | 214 | ||||||
Stock-based compensation expense
|
12,781 | 12,423 | ||||||
Deferred income taxes
|
4,302 | (9,183 | ) | |||||
Excess tax benefit from stock-based compensation
|
(1,523 | ) | (2,911 | ) | ||||
Changes in (net of the effect from acquisitions):
|
||||||||
Receivables
|
20,100 | 4,818 | ||||||
Inventories
|
20,774 | (4,643 | ) | |||||
Trade accounts payable
|
(12,762 | ) | (243 | ) | ||||
Accrued expenses
|
(9,005 | ) | 1,291 | |||||
Other net
|
131 | (3,381 | ) | |||||
Net cash flows provided by operating activities
|
157,674 | 168,113 | ||||||
Cash flows from investing activities
|
||||||||
Additions to property, plant and equipment
|
(18,346 | ) | (19,104 | ) | ||||
Acquisition of businesses, net of cash acquired
|
| (156,180 | ) | |||||
Proceeds from fixed assets disposals
|
3,582 | | ||||||
Change in restricted cash
|
| 140,005 | ||||||
Other net
|
329 | | ||||||
Net cash flows used in investing activities
|
(14,435 | ) | (35,279 | ) | ||||
Cash flows from financing activities
|
||||||||
Borrowings under credit facilities
|
64,906 | 446,925 | ||||||
Payments under credit facilities
|
(174,203 | ) | (279,278 | ) | ||||
Payment of senior notes
|
| (150,000 | ) | |||||
Dividends paid
|
(28,969 | ) | (29,496 | ) | ||||
Proceeds from stock option exercises
|
3,692 | 9,407 | ||||||
Excess tax benefit from stock-based compensation
|
1,523 | 2,911 | ||||||
Other net
|
(1,204 | ) | (950 | ) | ||||
Net cash flows used in financing activities
|
(134,255 | ) | (481 | ) | ||||
Effect of exchange rate changes on cash and cash equivalents
|
4,092 | (1,133 | ) | |||||
Net increase in cash
|
13,076 | 131,220 | ||||||
Cash and cash equivalents at beginning of year
|
61,353 | 102,757 | ||||||
Cash and cash equivalents at end of period
|
$ | 74,429 | $ | 233,977 | ||||
Supplemental cash flow information
|
||||||||
Cash paid for:
|
||||||||
Interest
|
$ | 13,400 | $ | 15,275 | ||||
Income taxes
|
31,853 | 58,623 | ||||||
Significant non-cash activities:
|
||||||||
Capital expenditures included in accounts payable
|
432 | 621 | ||||||
Issuance of unvested shares
|
4,895 | |
See Notes to Condensed Consolidated Financial Statements.
4
Table of Contents
IDEX
CORPORATION AND SUBSIDIARIES
(unaudited)
1. | Basis of Presentation and Significant Accounting Policies |
The Condensed Consolidated Financial Statements of IDEX
Corporation (IDEX or the Company) have
been prepared in accordance with the instructions to
Form 10-Q
under the Securities Exchange Act of 1934, as amended. The
statements are unaudited but include all adjustments, consisting
only of recurring items, except as noted, which the Company
considers necessary for a fair presentation of the information
set forth herein. The results of operations for the three and
nine months ended September 30, 2009 are not necessarily
indicative of the results to be expected for the entire year.
The condensed consolidated financial statements and
Managements Discussion and Analysis of Financial Condition
and Results of Operations should be read in conjunction with the
Companys Annual Report on
Form 10-K
for the fiscal year ended December 31, 2008.
Adoption
of New Accounting Standards
On July 1, 2009 the Financial Accounting Standards Board
(FASB) Accounting Standards
Codificationtm
(ASC) became the authoritative source of accounting
principals to be applied to financial statements prepared in
accordance with U.S. Generally Accepted Accounting
Principles (GAAP). In accordance with the ASC,
citations to accounting literature in this report are to the
relevant topic of the ASC or are presented in plain English.
This standard is effective for financial statements issued for
interim and annual periods ending after September 15, 2009.
The Company adopted this standard at its effective date.
In May 2009, the FASB issued an update to ASC 855
Subsequent Events. This standard establishes general
standards of accounting for and disclosure of events that occur
after the balance sheet date, but before the financial
statements are issued or available to be issued
(subsequent events). This standard requires
disclosure of the date through which the entity has evaluated
subsequent events and the basis for that date. For public
entities, this is the date the financial statements are issued.
This standard does not apply to subsequent events or
transactions that are within the scope of other GAAP and will
not result in significant changes in the subsequent events
reported by the Company. This standard is effective for interim
or annual periods ending after June 15, 2009. The Company
has adopted this standard at its effective date.
In April 2009, the FASB issued an update to ASC 820 Fair
Value Measurements and Disclosures and ASC 270
Interim Reporting. This standard requires
disclosures about fair value of financial instruments in interim
and annual financial statements. This standard is effective for
periods ending after June 15, 2009. The Company has adopted
this standard at its effective date.
In June 2008, the FASB issued an update to ASC 260,
Earnings Per Share. This standard addresses whether
instruments granted in share-based payment transactions are
participating securities prior to vesting and, therefore, need
to be included in the allocation in computing earnings per share
under the two-class method described in FASB ASC 260,
Earnings Per Share. The FASB concluded that all
outstanding unvested share-based payment awards that contain
rights to nonforfeitable dividends participate in undistributed
earnings with common shareholders. If awards are considered
participating securities, the Company is required to apply the
two-class method of computing basic and diluted earnings per
share. The Company has determined that its outstanding unvested
shares are participating securities. Accordingly, effective
January 1, 2009, earnings per common share are computed
using the two-class method prescribed by ASC 260. All previously
reported earnings per common share data has been retrospectively
adjusted to conform to the new computation method (see
Note 4).
In December 2007, the FASB issued an update to ASC 805
Business Combinations. The objective of the standard
is to establish principles and requirements for how an acquirer
in a business combination recognizes and measures in its
financial statements, the identifiable assets acquired, the
liabilities assumed, and any controlling interest; recognizes
and measures the goodwill acquired in the business combination
or a gain from a bargain purchase; and determines what
information to disclose to enable users of the financial
statements to evaluate the
5
Table of Contents
IDEX
CORPORATION AND SUBSIDIARIES
NOTES TO
CONDENSED CONSOLIDATED FINANCIAL
STATEMENTS (Continued)
nature and financial effects of the business combination. This
standard is to be applied prospectively to business combinations
for which the acquisition date is on or after an entitys
fiscal year that begins after December 15, 2008. The
Company will adopt this standard for all future acquisitions.
In December 2007, the FASB issued an update to ASC 810
Consolidation. The objective of the standard is to
change the financial accounting and reporting for noncontrolling
(or minority) interests in consolidated financial statements.
The provisions of this standard in part; establish accounting
and reporting standards for the noncontrolling interest in a
subsidiary and for the deconsolidation of a subsidiary;
clarifies that a noncontrolling interest in a subsidiary is an
ownership interest in the consolidated entity that should be
reported as equity in the consolidated financial statements;
establishes a single method of accounting for changes in a
parents ownership interest in a subsidiary that do not
result in deconsolidation; requires that a parent recognize a
gain or loss in net income when a subsidiary is deconsolidated;
and requires expanded disclosures in the consolidated financial
statements that clearly identify and distinguish between the
interests of the parents owners and the interests of the
noncontrolling owners of a subsidiary. ASC 810 is effective for
fiscal years, and interim periods within those fiscal years,
beginning on or after December 15, 2008. The adoption of
this standard effective January 2009 did not have an effect on
the consolidated financial position, results of operations or
cash flows of the Company.
Inventory
As of January 1, 2009, the Company changed its method for
accounting for certain inventories from
last-in,
first-out (LIFO) to
first-in,
first-out (FIFO). The company applied this change in accounting
principle retrospectively in accordance with FASB ASC 250,
Accounting Changes and Error Corrections (see
Note 5).
2. | Restructuring |
During the past five quarters, we have recorded restructuring
costs as a result of cost reduction efforts and facility
closings. Accruals have been recorded based on these costs and
primarily consist of employee termination benefits. We record
accruals for employee termination benefits based on the guidance
of FASB ASC 420, Exit or Disposal Cost Obligations.
These expenses are included in Restructuring expenses in the
Condensed Consolidated Statement of Operations while the
restructuring accruals are included in Accrued expenses in our
Condensed Consolidated Balance Sheets.
2009
Initiatives
During the three and nine months ended September 30, 2009,
the Company recorded pre-tax restructuring expenses totaling
$2.8 million and $8.3 million, respectively, for
employee severance related to employee reductions across various
functional areas as well as facility closures resulting from the
Companys cost savings initiatives. These initiatives
included severance benefits for 384 employees. The Company
is anticipating the employee reductions to be completed by the
end of 2009 with an expected additional total cost of
$2.0 $3.0 million during the fourth quarter,
with severance payments expected to be fully paid by the end of
2010 using cash from operations.
2008
Initiatives
For the full year 2008, the Company recorded pre-tax
restructuring expenses totaling $18.0 million for employee
severance related to employee reductions across various
functional areas as well as facility closures resulting from our
cost savings initiatives. These initiatives included severance
benefits for 380 employees. These employee reductions were
completed by the end of 2008, with severance payments expected
to be fully paid by the end of 2009 using cash from operations.
6
Table of Contents
IDEX
CORPORATION AND SUBSIDIARIES
NOTES TO
CONDENSED CONSOLIDATED FINANCIAL
STATEMENTS (Continued)
Pre-tax restructuring expenses, by segment for the three months
ended September 30, 2009, were as follows:
Asset |
||||||||||||
Write-downs |
||||||||||||
Severance |
& Exit |
|||||||||||
Costs | Costs | Total | ||||||||||
(in thousands) | ||||||||||||
Fluid & Metering Technologies
|
$ | 657 | $ | | $ | 657 | ||||||
Health & Science Technologies
|
841 | 184 | 1,025 | |||||||||
Dispensing Equipment
|
630 | | 630 | |||||||||
Fire & Safety/Diversified Products
|
24 | | 24 | |||||||||
Corporate/Other
|
202 | 214 | 416 | |||||||||
Total restructuring costs
|
$ | 2,354 | $ | 398 | $ | 2,752 | ||||||
Pre-tax restructuring expenses, by segment for the nine months
ended September 30, 2009, were as follows:
Asset |
||||||||||||
Write-downs |
||||||||||||
Severance |
& Exit |
|||||||||||
Costs | Costs | Total | ||||||||||
(in thousands) | ||||||||||||
Fluid & Metering Technologies
|
$ | 2,552 | $ | 490 | $ | 3,042 | ||||||
Health & Science Technologies
|
2,123 | 596 | 2,719 | |||||||||
Dispensing Equipment
|
347 | 860 | 1,207 | |||||||||
Fire & Safety/Diversified Products
|
474 | | 474 | |||||||||
Corporate/Other
|
441 | 370 | 811 | |||||||||
Total restructuring costs
|
$ | 5,937 | $ | 2,316 | $ | 8,253 | ||||||
Restructuring accruals of $9.3 million at both
September 30, 2009 and December 31, 2008,
respectively, are reflected in Accrued expenses in our Condensed
Consolidated Balance Sheets as follows:
2008 |
2009 |
|||||||||||
Initiatives | Initiatives | Total | ||||||||||
(in thousands) | ||||||||||||
Balance at January 1, 2009
|
$ | 9,263 | $ | | $ | 9,263 | ||||||
Restructuring costs/reversals
|
828 | 7,425 | 8,253 | |||||||||
Acquisition related
|
| 3,927 | 3,927 | |||||||||
Payments/utilization
|
(7,279 | ) | (4,894 | ) | (12,173 | ) | ||||||
Balance at September 30, 2009
|
$ | 2,812 | $ | 6,458 | $ | 9,270 | ||||||
3. | Business Segments |
The Company consists of four reportable segments:
Fluid & Metering Technologies, Health &
Science Technologies, Dispensing Equipment and Fire &
Safety/Diversified Products.
The Fluid & Metering Technologies Segment produces
pumps, flow meters, and related controls for the movement of
liquids and gases in a diverse range of end markets from
industrial infrastructure to food and beverage. The
Health & Science Technologies Segment produces a wide
variety of small-scale, highly accurate pumps, valves, fittings
and medical devices, as well as compressors used in medical,
dental and industrial applications. The Dispensing Equipment
Segment produces highly engineered equipment for dispensing,
metering and mixing colorants, paints, inks and dyes,
refinishing equipment, as well as the food industry. The
Fire & Safety/Diversified Products Segment produces
firefighting pumps, rescue tools, lifting bags and other
components and systems for the
7
Table of Contents
IDEX
CORPORATION AND SUBSIDIARIES
NOTES TO
CONDENSED CONSOLIDATED FINANCIAL
STATEMENTS (Continued)
fire and rescue industry, as well as engineered stainless steel
banding and clamping devices used in a variety of industrial and
commercial applications.
Information on the Companys business segments is presented
below, based on the nature of products and services offered. The
Company evaluates performance based on several factors, of which
operating income is the primary financial measure. Intersegment
sales are accounted for at fair value as if the sales were to
third parties.
Three Months |
Nine Months |
|||||||||||||||
Ended |
Ended |
|||||||||||||||
September 30, | September 30, | |||||||||||||||
2009 | 2008 | 2009 | 2008 | |||||||||||||
(In thousands) | ||||||||||||||||
Net sales
|
||||||||||||||||
Fluid & Metering Technologies:
|
||||||||||||||||
External customers
|
$ | 156,781 | $ | 169,957 | $ | 470,271 | $ | 517,641 | ||||||||
Intersegment sales
|
158 | 301 | 686 | 905 | ||||||||||||
Total group sales
|
156,939 | 170,258 | 470,957 | 518,546 | ||||||||||||
Health & Science Technologies:
|
||||||||||||||||
External customers
|
75,365 | 82,506 | 219,305 | 251,279 | ||||||||||||
Intersegment sales
|
773 | 383 | 4,837 | 2,499 | ||||||||||||
Total group sales
|
76,138 | 82,889 | 224,142 | 253,778 | ||||||||||||
Dispensing Equipment:
|
||||||||||||||||
External customers
|
25,580 | 31,543 | 104,111 | 138,152 | ||||||||||||
Intersegment sales
|
| | | | ||||||||||||
Total group sales
|
25,580 | 31,543 | 104,111 | 138,152 | ||||||||||||
Fire & Safety/Diversified Products:
|
||||||||||||||||
External customers
|
65,523 | 81,187 | 192,630 | 227,093 | ||||||||||||
Intersegment sales
|
1 | 2 | 3 | 6 | ||||||||||||
Total group sales
|
65,524 | 81,189 | 192,633 | 227,099 | ||||||||||||
Intersegment elimination
|
(932 | ) | (686 | ) | (5,526 | ) | (3,410 | ) | ||||||||
Total net sales
|
$ | 323,249 | $ | 365,193 | $ | 986,317 | $ | 1,134,165 | ||||||||
Operating income (loss)
|
||||||||||||||||
Fluid & Metering Technologies
|
$ | 25,755 | $ | 33,656 | $ | 70,731 | $ | 98,227 | ||||||||
Health & Science Technologies
|
14,287 | 17,012 | 34,703 | 47,896 | ||||||||||||
Dispensing
Equipment(1)
|
(311 | ) | (32,026 | ) | 13,112 | (6,526 | ) | |||||||||
Fire & Safety/Diversified Products
|
15,932 | 20,401 | 42,790 | 56,959 | ||||||||||||
Corporate office and other
|
(9,146 | ) | (8,239 | ) | (28,923 | ) | (28,230 | ) | ||||||||
Total operating income
|
$ | 46,517 | $ | 30,804 | $ | 132,413 | $ | 168,326 | ||||||||
(1) | Segment operating income includes $30.1 million goodwill impairment charge in 2008 for Fluid Management Americas. |
8
Table of Contents
IDEX
CORPORATION AND SUBSIDIARIES
NOTES TO
CONDENSED CONSOLIDATED FINANCIAL
STATEMENTS (Continued)
4. | Earnings Per Common Share |
Earnings per common share (EPS) is computed by
dividing net income by the weighted average number of shares of
common stock (basic) plus common stock equivalents outstanding
(diluted) during the period. Common stock equivalents consist of
stock options, which have been included in the calculation of
weighted average shares outstanding using the treasury stock
method, unvested shares, and shares issuable in connection with
certain deferred compensation agreements (DCUs).
ASC 260, Earnings Per Share, concludes that all
outstanding unvested share-based payment awards that contain
rights to nonforfeitable dividends participate in undistributed
earnings with common shareholders. If awards are considered
participating securities, the Corporation is required to apply
the two-class method of computing basic and diluted earnings per
share. The Corporation has determined that its outstanding
unvested shares are participating securities. Accordingly,
effective January 1, 2009, earnings per common share are
computed using the two-class method prescribed by ASC 260. All
previously reported earnings per common share data has been
retrospectively adjusted to conform to the new computation
method. Net income attributable to common shareholders was
reduced by $0.2 million and $0.1 million for the three
months ended September 30, 2009 and 2008, respectively. Net
income attributable to common shareholders was reduced by
$0.6 million and $0.9 million for the nine months
ended September 30, 2009 and 2008, respectively.
Basic weighted average shares reconciles to diluted weighted
average shares as follows:
Three Months |
Nine Months |
|||||||||||||||
Ended September 30, | Ended September 30, | |||||||||||||||
2009 | 2008 | 2009 | 2008 | |||||||||||||
(In thousands) | ||||||||||||||||
Basic weighted average common shares outstanding
|
79,740 | 81,572 | 79,642 | 81,320 | ||||||||||||
Dilutive effect of stock options, unvested shares, and DCUs
|
1,139 | 1,385 | 893 | 1,343 | ||||||||||||
Diluted weighted average common shares outstanding
|
80,879 | 82,957 | 80,535 | 82,663 | ||||||||||||
Options to purchase approximately 2.5 million and
2.0 million shares of common stock as of September 30,
2009 and 2008, respectively, were not included in the
computation of diluted EPS because the exercise price was
greater than the average market price of the Companys
common stock and, therefore, the effect of their inclusion would
be antidilutive.
5. | Inventories |
Inventories are stated at the lower of cost or market. Cost,
which includes material, labor, and factory overhead, is
determined on a FIFO basis.
9
Table of Contents
IDEX
CORPORATION AND SUBSIDIARIES
NOTES TO
CONDENSED CONSOLIDATED FINANCIAL
STATEMENTS (Continued)
Prior to 2009, we valued certain inventories under the LIFO cost
method. As of January 1, 2009, we changed our method of
accounting for these inventories from the LIFO method to the
FIFO method. As of December 31, 2008, the inventories for
which the LIFO method of accounting was applied represented
approximately 85% of total net inventories. We believe that this
change is to a preferable method which better reflects the
current cost of inventory on our consolidated balance sheets.
Additionally, this change conforms all of our worldwide
inventories to a consistent inventory costing method and
provides better comparability to our peers. We applied this
change in accounting principle retrospectively to all prior
periods presented herein in accordance with FASB ASC 250,
Accounting Changes and Error Corrections. As a
result of this accounting change, our retained earnings as of
December 31, 2008 decreased to $822.3 million using
the FIFO method from $845.4 million as originally reported
using the LIFO method. The following tables summarize the effect
of the accounting change on our consolidated financial
statements.
Three Months Ended |
Three Months Ended |
|||||||||||||||||||||||
September 30, 2009 | September 30, 2008 | |||||||||||||||||||||||
As |
||||||||||||||||||||||||
Computed |
Effect |
Computed |
Effect |
|||||||||||||||||||||
Under Prior |
of |
Under |
Originally |
of |
As |
|||||||||||||||||||
Method | Change | FIFO | Reported | Change | Adjusted | |||||||||||||||||||
(Thousands, except per share data) | ||||||||||||||||||||||||
Statement of Operations:
|
||||||||||||||||||||||||
Cost of sales
|
$ | 194,794 | $ | (603 | ) | $ | 194,191 | $ | 218,796 | $ | (1,387 | ) | $ | 217,409 | ||||||||||
Income taxes
|
13,954 | 217 | 14,171 | 9,204 | 579 | 9,783 | ||||||||||||||||||
Net income
|
29,391 | 386 | 29,777 | 19,075 | 808 | 19,883 | ||||||||||||||||||
Per common share:
|
||||||||||||||||||||||||
Basic earnings
|
0.36 | 0.01 | 0.37 | 0.23 | 0.01 | 0.24 | ||||||||||||||||||
Diluted earnings
|
0.36 | 0.01 | 0.37 | 0.23 | 0.01 | 0.24 | ||||||||||||||||||
Statement of Cash Flows:
|
||||||||||||||||||||||||
Net income
|
29,391 | 386 | 29,777 | 19,075 | 808 | 19,883 | ||||||||||||||||||
Deferred income tax liability
|
(2,607 | ) | 217 | (2,390 | ) | (11,259 | ) | 579 | (10,680 | ) | ||||||||||||||
Inventory working capital change
|
7,293 | (603 | ) | 6,690 | 2,232 | (1,527 | ) | 705 | ||||||||||||||||
Net cash provided by operating activities
|
84,763 | | 84,763 | 72,836 | | 72,836 |
Nine Months Ended |
Nine Months Ended |
|||||||||||||||||||||||
September 30, 2009 | September 30, 2008 | |||||||||||||||||||||||
As |
||||||||||||||||||||||||
Computed |
Effect |
Computed |
Effect |
|||||||||||||||||||||
Under Prior |
of |
Under |
Originally |
of |
As |
|||||||||||||||||||
Method | Change | FIFO | Reported | Change | Adjusted | |||||||||||||||||||
(Thousands, except per share data) | ||||||||||||||||||||||||
Statement of Operations:
|
||||||||||||||||||||||||
Cost of sales
|
$ | 600,119 | $ | 2,845 | $ | 602,964 | $ | 669,393 | $ | 2,998 | $ | 672,391 | ||||||||||||
Income taxes
|
40,645 | (942 | ) | 39,703 | 55,082 | (1,036 | ) | 54,046 | ||||||||||||||||
Net income
|
82,207 | (1,903 | ) | 80,304 | 106,508 | (1,962 | ) | 104,546 | ||||||||||||||||
Per common share:
|
||||||||||||||||||||||||
Basic earnings
|
1.02 | (0.02 | ) | 1.00 | 1.31 | (0.04 | ) | 1.27 | ||||||||||||||||
Diluted earnings
|
1.01 | (0.02 | ) | 0.99 | 1.29 | (0.03 | ) | 1.26 | ||||||||||||||||
Statement of Cash Flows:
|
||||||||||||||||||||||||
Net income
|
82,207 | (1,903 | ) | 80,304 | 106,508 | (1,962 | ) | 104,546 | ||||||||||||||||
Deferred income tax liability
|
5,244 | (942 | ) | 4,302 | (8,147 | ) | (1,036 | ) | (9,183 | ) | ||||||||||||||
Inventory working capital change
|
17,929 | 2,845 | 20,774 | (7,368 | ) | 2,725 | (4,643 | ) | ||||||||||||||||
Net cash provided by operating activities
|
157,674 | | 157,674 | 168,113 | | 168,113 |
10
Table of Contents
IDEX
CORPORATION AND SUBSIDIARIES
NOTES TO
CONDENSED CONSOLIDATED FINANCIAL
STATEMENTS (Continued)
September 30, 2009 | December 31, 2008 | |||||||||||||||||||||||
Balance Sheet:
|
||||||||||||||||||||||||
Inventories
|
$ | 198,189 | $ | (35,805 | ) | $ | 162,384 | $ | 214,160 | $ | (32,960 | ) | $ | 181,200 | ||||||||||
Other current assets (prepaid taxes)
|
22,978 | 9,385 | 32,363 | 24,423 | 8,443 | 32,866 | ||||||||||||||||||
Accrued expenses (income tax payable)
|
114,062 | 614 | 114,676 | 116,572 | 614 | 117,186 | ||||||||||||||||||
Deferred income tax liability
|
149,209 | (2,352 | ) | 146,857 | 144,336 | (2,352 | ) | 141,984 | ||||||||||||||||
Cumulative translation adjustment
|
63,500 | 262 | 63,762 | 39,873 | 331 | 40,204 | ||||||||||||||||||
Retained earnings
|
898,603 | (25,013 | ) | 873,590 | 845,396 | (23,110 | ) | 822,286 | ||||||||||||||||
The revised components of inventories as of September 30,
2009 and December 31, 2008 were as follows:
September 30, |
December 31, |
|||||||
2009 | 2008 | |||||||
(In thousands) | ||||||||
Raw materials and component parts
|
$ | 104,087 | $ | 110,290 | ||||
Work-in-process
|
20,345 | 22,483 | ||||||
Finished goods
|
37,952 | 48,427 | ||||||
Total
|
$ | 162,384 | $ | 181,200 | ||||
6. | Goodwill and Intangible Assets |
The changes in the carrying amount of goodwill for the nine
months ended September 30, 2009, by reporting segment, were
as follows:
Fluid & |
Health & |
Fire & Safety/ |
||||||||||||||||||
Metering |
Science |
Dispensing |
Diversified |
|||||||||||||||||
Technologies | Technologies | Equipment | Products | Total | ||||||||||||||||
(In thousands) | ||||||||||||||||||||
Balance at December 31, 2008
|
$ | 524,387 | $ | 391,654 | $ | 103,470 | $ | 147,552 | $ | 1,167,063 | ||||||||||
Foreign currency translation
|
8,428 | 496 | 2,993 | 2,515 | 14,432 | |||||||||||||||
Acquisition adjustments
|
3,657 | 1,004 | | | 4,661 | |||||||||||||||
Balance at September 30, 2009
|
$ | 536,472 | $ | 393,154 | $ | 106,463 | $ | 150,067 | $ | 1,186,156 | ||||||||||
For acquisitions completed in the fourth quarter of 2008, the
Company is in the process of finalizing appraisals of tangible
and intangible assets and is continuing to complete the purchase
price allocations, which will be adjusted as additional
information relative to the fair values of the assets and
liabilities becomes known.
Acquisition adjustments during the nine months ended
September 30, 2009 primarily relate to restructuring
charges and other fair value adjustments of $4.3 million
recorded by Richter Chemie-Technik, a business unit within the
Companys Fluid & Metering Technologies Segment,
offset by other various acquisition adjustments. The
restructuring charges were primarily employee severance related
to employee reductions across various functional areas.
ASC 350, Goodwill and Other Intangible Assets,
requires that goodwill be tested for impairment at the reporting
unit level on an annual basis and between annual tests if an
event occurs or circumstances change that would more likely than
not reduce the fair value of the reporting unit below its
carrying value. Annually on
October 31st,
goodwill and other acquired intangible assets with indefinite
lives are tested for impairment. The Company concluded that the
fair value of each of the reporting units was in excess of the
carrying value as of
11
Table of Contents
IDEX
CORPORATION AND SUBSIDIARIES
NOTES TO
CONDENSED CONSOLIDATED FINANCIAL
STATEMENTS (Continued)
October 31, 2008. The Company did not consider there to be
any triggering event that would require an interim impairment
assessment, therefore none of the goodwill or other acquired
intangible assets with indefinite lives were tested for
impairment during the nine months ended September 30, 2009.
The following table provides the gross carrying value and
accumulated amortization for each major class of intangible
asset as of September 30, 2009 and December 31, 2008:
September 30, 2009 | December 31, 2008 | |||||||||||||||||||
Gross |
Weighted |
Gross |
||||||||||||||||||
Carrying |
Accumulated |
Average |
Carrying |
Accumulated |
||||||||||||||||
Amount | Amortization | Lives | Amount | Amortization | ||||||||||||||||
(In thousands) | ||||||||||||||||||||
Amortizable intangible assets:
|
||||||||||||||||||||
Patents
|
$ | 11,917 | $ | (6,048 | ) | 11 | $ | 11,795 | $ | (5,550 | ) | |||||||||
Trade names
|
64,078 | (9,448 | ) | 15 | 62,805 | (6,310 | ) | |||||||||||||
Customer relationships
|
158,513 | (28,577 | ) | 12 | 156,216 | (16,601 | ) | |||||||||||||
Non-compete agreements
|
4,276 | (3,214 | ) | 4 | 4,569 | (2,989 | ) | |||||||||||||
Unpatented technology
|
36,093 | (5,442 | ) | 14 | 35,527 | (2,939 | ) | |||||||||||||
Other
|
6,236 | (2,088 | ) | 10 | 6,282 | (1,679 | ) | |||||||||||||
Total amortizable intangible assets
|
281,113 | (54,817 | ) | 277,194 | (36,068 | ) | ||||||||||||||
Banjo trade name
|
62,100 | | 62,100 | | ||||||||||||||||
$ | 343,213 | $ | (54,817 | ) | $ | 339,294 | $ | (36,068 | ) | |||||||||||
The Banjo trade name is an indefinite lived intangible asset
which is tested for impairment on an annual basis or more
frequently if events or changes in circumstances indicate that
the asset might be impaired.
7. | Accrued Expenses |
The components of accrued expenses as of September 30, 2009
and December 31, 2008 were:
September 30, |
December 31, |
|||||||
2009 | 2008 | |||||||
(In thousands) | ||||||||
Payroll and related items
|
$ | 47,053 | $ | 45,162 | ||||
Management incentive compensation
|
7,009 | 10,078 | ||||||
Income taxes payable
|
8,420 | 8,275 | ||||||
Deferred income taxes
|
847 | 1,469 | ||||||
Insurance
|
9,081 | 9,964 | ||||||
Warranty
|
4,304 | 3,751 | ||||||
Deferred revenue
|
4,201 | 2,600 | ||||||
Restructuring
|
9,270 | 9,263 | ||||||
Other
|
24,491 | 26,624 | ||||||
Total accrued expenses
|
$ | 114,676 | $ | 117,186 | ||||
12
Table of Contents
IDEX
CORPORATION AND SUBSIDIARIES
NOTES TO
CONDENSED CONSOLIDATED FINANCIAL
STATEMENTS (Continued)
8. | Borrowings |
Borrowings at September 30, 2009 and December 31, 2008
consisted of the following:
September 30, |
December 31, |
|||||||
2009 | 2008 | |||||||
(In thousands) | ||||||||
Credit Facility
|
$ | 347,664 | $ | 448,763 | ||||
Term Loan
|
95,000 | 100,000 | ||||||
Other borrowings
|
4,475 | 5,237 | ||||||
Total borrowings
|
447,139 | 554,000 | ||||||
Less current portion
|
6,307 | 5,856 | ||||||
Total long-term borrowings
|
$ | 440,832 | $ | 548,144 | ||||
The Company maintains a $600.0 million unsecured domestic,
multi-currency bank revolving credit facility (Credit
Facility), which expires on December 21, 2011. In
2008, the Credit Facility was amended to allow the Company to
designate certain foreign subsidiaries as designated borrowers.
Upon approval from the lenders, the designated borrowers were
allowed to receive loans under the Credit Facility. A designated
borrower sublimit was established as the lesser of the aggregate
commitments or $100.0 million. As of the amendment date,
Fluid Management Europe B.V., (FME) was approved by the lenders
as a designated borrower. FMEs borrowings under the Credit
Facility at September 30, 2009 were approximately
$65.7 million (Euro 45.0 million). As the FME
borrowings under the Credit Facility are Euro denominated and
the cash flows that will be used to make payments of principal
and interest are predominately denominated in Euros, the Company
does not anticipate any significant foreign exchange gains or
losses in servicing this debt.
At September 30, 2009 there was $347.7 million
outstanding under the Credit Facility and outstanding letters of
credit totaled approximately $7.1 million. The net
available borrowing under the Credit Facility as of
September 30, 2009, was approximately $245.2 million.
Interest is payable quarterly on the outstanding borrowings at
the bank agents reference rate. Interest on borrowings
based on LIBOR plus an applicable margin is payable on the
maturity date of the borrowing, or quarterly from the effective
date for borrowings exceeding three months. The applicable
margin is based on the Companys senior, unsecured,
long-term debt rating and can range from 24 basis points to
50 basis points. Based on the Companys BBB rating at
September 30, 2009, the applicable margin was 40 basis
points. An annual Credit Facility fee, also based on the
Companys credit rating, is currently 10 basis points
and is payable quarterly.
At September 30, 2009 the Company had one interest rate
exchange agreement related to the Credit Facility. The interest
rate exchange agreement, expiring in January 2011, effectively
converted $250.0 million of floating-rate debt into
fixed-rate debt at an interest rate of 3.25%. The fixed rate
noted above is comprised of the fixed rate on the interest rate
exchange agreement and the Companys current margin of
40 basis points on the Credit Facility.
On April 18, 2008, the Company completed a
$100.0 million unsecured senior bank term loan agreement
(Term Loan) with covenants consistent with the
existing Credit Facility and a maturity on December 21,
2011. At September 30, 2009, there was $95.0 million
outstanding under the Term Loan with $5.0 million included
within short term borrowings. Interest under the Term Loan is
based on the bank agents reference rate or LIBOR plus an
applicable margin and is payable at the end of the selected
interest period, but at least quarterly. The applicable margin
is based on the Companys senior, unsecured, long-term debt
rating and can range from 45 to 100 basis points. Based on
the Companys current debt rating, the applicable margin is
80 basis points. The Term Loan requires repayments of
$5.0 million and $7.5 million in April of 2010 and
2011, respectively, with the remaining balance due on
December 21, 2011. The Company used the proceeds from the
Term Loan to pay down existing debt outstanding under the Credit
Facility.
13
Table of Contents
IDEX
CORPORATION AND SUBSIDIARIES
NOTES TO
CONDENSED CONSOLIDATED FINANCIAL
STATEMENTS (Continued)
At September 30, 2009 the Company had an interest rate
exchange agreement related to the Term Loan that expires
December 2011. With a current notional amount of
$95.0 million, the agreement effectively converted
$100.0 million of floating-rate debt into fixed-rate debt
at an interest rate of 4.00%. The fixed rate is comprised of the
fixed rate on the interest rate exchange agreement and the
Companys current margin of 80 basis points on the
Term Loan.
9. | Derivative Instruments |
ASC 815 Derivatives and Hedging, requires that a
Company with derivative instruments disclose information to
enable users of the financial statements to understand: how and
why an entity uses derivative instruments; how derivative
instruments and related hedged items are accounted for; and how
derivative instruments and related hedged items affect an
entitys financial position, financial performance, and
cash flows. As such, ASC 815 requires qualitative disclosures
about objectives and strategies for using derivatives,
quantitative disclosures about fair value amounts of and gains
and losses on derivative instruments, and disclosures about
credit-risk-related contingent features in derivative agreements.
The Company enters into cash flow hedges to reduce the exposure
to variability in certain expected future cash flows. The type
of cash flow hedges the Company enters into includes foreign
currency contracts and interest rate exchange agreements that
effectively convert a portion of floating-rate debt to
fixed-rate debt and are designed to reduce the impact of
interest rate changes on future interest expense.
The effective portion of gains or losses on interest rate
exchange agreements is reported in accumulated other
comprehensive income in shareholders equity and
reclassified into net income in the same period or periods in
which the hedged transaction affects net income. The remaining
gain or loss in excess of the cumulative change in the present
value of future cash flows or the hedged item, if any, is
recognized into net income during the period of change.
Fair values relating to derivative financial instruments reflect
the estimated amounts that the Company would receive or pay to
sell or buy the contracts based on quoted market prices of
comparable contracts at each balance sheet date.
At September 30, 2009, the Company had two interest rate
exchange agreements. The first interest rate exchange agreement,
expiring in January 2011, effectively converted
$250.0 million of floating-rate debt into fixed-rate debt
at an interest rate of 3.25%. The second interest rate exchange
agreement, expiring December 2011, with a current notional
amount of $95.0 million, effectively converted
$100.0 million of floating-rate debt into fixed-rate debt
at an interest rate of 4.00%. The fixed rate is comprised of the
fixed rate on the interest rate exchange agreements and the
Companys current margin of 40 basis points for the
Credit Facility and 80 basis points on the Term Loan.
Based on interest rates at September 30, 2009,
approximately $9.3 million of the amount included in
accumulated other comprehensive income (loss) in
shareholders equity at September 30, 2009 will be
recognized to net income over the next 12 months as the
underlying hedged transactions are realized.
At September 30, 2009, the Company had foreign currency
exchange contracts with an aggregate notional amount of
$3.4 million to manage its exposure to fluctuations in
foreign currency exchange rates. The change in fair market value
of these contracts for the nine months ended September 30,
2009 was immaterial.
The following tables set forth the fair value amounts of
derivative instruments held by the Company as of
September 30, 2009 and December 31, 2008:
Fair Value-Assets | ||||||||||||
September 30, |
December 31, |
|||||||||||
2009 | 2008 | Balance Sheet Caption | ||||||||||
(In thousands) | ||||||||||||
Foreign exchange contracts
|
$ | 452 | $ | | Current assets |
14
Table of Contents
IDEX
CORPORATION AND SUBSIDIARIES
NOTES TO
CONDENSED CONSOLIDATED FINANCIAL
STATEMENTS (Continued)
Fair Value-Liabilities | ||||||||||||
September 30, |
December 31, |
|||||||||||
2009 | 2008 |
Balance Sheet Caption
|
||||||||||
(In thousands) | ||||||||||||
Interest rate contracts
|
$ | 11,573 | $ | 10,098 | Other noncurrent liabilities | |||||||
Foreign exchange contracts
|
| 272 | Accrued expenses | |||||||||
$ | 11,573 | $ | 10,370 | |||||||||
The following tables summarize the gain (loss) recognized and
the amounts and location of income (expense) and gain (loss)
reclassified into income for interest rate contracts and foreign
currency contracts as of September 30, 2009 and 2008:
Gain (Loss) |
Income (Expense) |
|||||||||||||||||||
Recognized in |
and Gain |
|||||||||||||||||||
Other |
(Loss) |
|||||||||||||||||||
Comprehensive |
Reclassified into |
|||||||||||||||||||
Income (Loss) | Income | |||||||||||||||||||
Three Months Ended September 30, |
Income |
|||||||||||||||||||
2009 | 2008 | 2009 | 2008 | Statement Caption | ||||||||||||||||
(In thousands) | ||||||||||||||||||||
Interest rate contracts
|
$ | (751 | ) | $ | (234 | ) | $ | (2,148 | ) | $ | (158 | ) | Interest expense | |||||||
Foreign exchange contracts
|
112 | | 346 | | Sales |
Gain (Loss) |
Income (Expense) |
|||||||||||||||||||
Recognized in |
and Gain |
|||||||||||||||||||
Other |
(Loss) |
|||||||||||||||||||
Comprehensive |
Reclassified into |
|||||||||||||||||||
Income (Loss) | Income |
Income |
||||||||||||||||||
Nine Months Ended September 30, |
Statement |
|||||||||||||||||||
2009 | 2008 | 2009 | 2008 |
Caption
|
||||||||||||||||
(In thousands) | ||||||||||||||||||||
Interest rate contracts
|
$ | (943 | ) | $ | 2,922 | $ | (5,757 | ) | $ | (106 | ) | Interest expense | ||||||||
Foreign exchange contracts
|
493 | | 399 | | Sales |
10. | Fair Value Measurements |
ASC 820, Fair Value Measurements and Disclosures defines
fair value, provides guidance for measuring fair value and
requires certain disclosures. This standard discusses valuation
techniques, such as the market approach (comparable market
prices), the income approach (present value of future income or
cash flow), and the cost approach (cost to replace the service
capacity of an asset or replacement cost). The standard utilizes
a fair value hierarchy that prioritizes the inputs to valuation
techniques used to measure fair value into three broad levels.
The following is a brief description of those three levels:
| Level 1: Observable inputs such as quoted prices (unadjusted) in active markets for identical assets or liabilities. | |
| Level 2: Inputs, other than quoted prices that are observable for the asset or liability, either directly or indirectly. These include quoted prices for similar assets or liabilities in active markets and quoted prices for identical or similar assets or liabilities in markets that are not active. | |
| Level 3: Unobservable inputs that reflect the reporting entitys own assumptions. |
15
Table of Contents
IDEX
CORPORATION AND SUBSIDIARIES
NOTES TO
CONDENSED CONSOLIDATED FINANCIAL
STATEMENTS (Continued)
The following table summarizes the basis used to measure the
Companys financial assets and liabilities at fair value on
a recurring basis in the balance sheet at September 30,
2009 and December 31, 2008:
Basis of Fair Value Measurements | ||||||||||||||||
Balance at |
||||||||||||||||
September 30, 2009 | Level 1 | Level 2 | Level 3 | |||||||||||||
(In thousands) | ||||||||||||||||
Interest rate exchange agreement derivative financial
instruments (included in Other noncurrent liabilities)
|
$ | 11,573 | | $ | 11,573 | | ||||||||||
Foreign currency contracts (included in Other current assets)
|
$ | 452 | | $ | 452 | |
Balance at |
||||||||||||||||
December 31, 2008 | Level 1 | Level 2 | Level 3 | |||||||||||||
(In thousands) | ||||||||||||||||
Interest rate exchange agreement derivative financial
instruments (included in Other noncurrent liabilities)
|
$ | 10,098 | | $ | 10,098 | | ||||||||||
Foreign currency contracts (included in Accrued expenses)
|
$ | 272 | | $ | 272 | |
In determining the fair value of the Companys interest
rate exchange agreement derivatives, the Company uses a present
value of expected cash flows based on market observable interest
rate yield curves commensurate with the term of each instrument
and the credit default swap market to reflect the credit risk of
either the Company or the counterparty.
The carrying value of our cash and cash equivalents, accounts
receivable, and accounts payable approximates their fair values
because of the short term nature of these instruments. At
September 30, 2009, the fair value of our long term debt,
based on the current market rates for debt with similar credit
risk and maturity, approximated the value recorded on our
balance sheet.
11. | Common and Preferred Stock |
At September 30, 2009 and December 31, 2008, the
Company had 150 million shares of authorized common stock,
with a par value of $.01 per share and 5 million shares of
preferred stock with a par value of $.01 per share. No preferred
stock was issued as of September 30, 2009 and
December 31, 2008.
12. | Share-Based Compensation |
During the nine months ended September 30, 2009, the
Company granted approximately 1.2 million stock options and
0.3 million unvested shares. During the nine months ended
September 30, 2008, the Company granted approximately
1.1 million stock options and 0.6 million unvested
shares.
16
Table of Contents
IDEX
CORPORATION AND SUBSIDIARIES
NOTES TO
CONDENSED CONSOLIDATED FINANCIAL
STATEMENTS (Continued)
Total compensation cost for stock options is as follows:
Three Months |
Nine Months |
|||||||||||||||
Ended September 30, | Ended September 30, | |||||||||||||||
2009 | 2008 | 2009 | 2008 | |||||||||||||
(In thousands) | ||||||||||||||||
Cost of goods sold
|
$ | 220 | $ | 256 | $ | 758 | $ | 843 | ||||||||
Selling, general and administrative expenses
|
1,455 | 1,772 | 5,109 | 5,786 | ||||||||||||
Total expense before income taxes
|
1,675 | 2,028 | 5,867 | 6,629 | ||||||||||||
Income tax benefit
|
(531 | ) | (645 | ) | (1,889 | ) | (2,102 | ) | ||||||||
Total expense after income taxes
|
$ | 1,144 | $ | 1,383 | $ | 3,978 | $ | 4,527 | ||||||||
Total compensation cost for unvested shares is as follows:
Three Months |
Nine Months |
|||||||||||||||
Ended September 30, | Ended September 30, | |||||||||||||||
2009 | 2008 | 2009 | 2008 | |||||||||||||
(In thousands) | ||||||||||||||||
Cost of goods sold
|
$ | 63 | $ | 24 | $ | 187 | $ | 55 | ||||||||
Selling, general and administrative expenses
|
2,072 | 2,160 | 6,727 | 5,739 | ||||||||||||
Total expense before income taxes
|
2,135 | 2,184 | 6,914 | 5,794 | ||||||||||||
Income tax benefit
|
(384 | ) | (378 | ) | (1,167 | ) | (1,097 | ) | ||||||||
Total expense after income taxes
|
$ | 1,751 | $ | 1,806 | $ | 5,747 | $ | 4,697 | ||||||||
Classification of stock compensation cost within the Condensed
Consolidated Statements of Operations is consistent with
classification of cash compensation for the same employees, and
compensation cost capitalized as part of inventory was
immaterial.
As of September 30, 2009, there was $11.6 million of
total unrecognized compensation cost related to stock options
that is expected to be recognized over a weighted-average period
of 1.4 years, and $13.3 million of total unrecognized
compensation cost related to unvested shares that is expected to
be recognized over a weighted-average period of 1.2 years.
13. | Retirement Benefits |
The Company sponsors several qualified and nonqualified defined
benefit and defined contribution pension plans and other
postretirement plans for its employees. The following tables
provide the components of net periodic benefit cost for its
major defined benefit plans and its other postretirement plans.
Pension Benefits | ||||||||||||||||||||
Three Months Ended September 30, | ||||||||||||||||||||
2009 | 2008 | |||||||||||||||||||
U.S. | Non-U.S. | U.S. | Non-U.S. | |||||||||||||||||
(In thousands) | ||||||||||||||||||||
Service cost
|
$ | 388 | $ | 214 | $ | 442 | $ | 220 | ||||||||||||
Interest cost
|
1,093 | 549 | 1,121 | 455 | ||||||||||||||||
Expected return on plan assets
|
(876 | ) | (205 | ) | (1,292 | ) | (260 | ) | ||||||||||||
Net amortization
|
1,218 | 96 | 516 | 100 | ||||||||||||||||
Net periodic benefit cost
|
$ | 1,823 | $ | 654 | $ | 787 | $ | 515 | ||||||||||||
17
Table of Contents
IDEX
CORPORATION AND SUBSIDIARIES
NOTES TO
CONDENSED CONSOLIDATED FINANCIAL
STATEMENTS (Continued)
Pension Benefits | ||||||||||||||||
Nine Months Ended September 30, | ||||||||||||||||
2009 | 2008 | |||||||||||||||
U.S. | Non-U.S. | U.S. | Non-U.S. | |||||||||||||
(In thousands) | ||||||||||||||||
Service cost
|
$ | 1,164 | $ | 609 | $ | 1,324 | $ | 674 | ||||||||
Interest cost
|
3,281 | 1,562 | 3,363 | 1,394 | ||||||||||||
Expected return on plan assets
|
(2,629 | ) | (577 | ) | (3,877 | ) | (801 | ) | ||||||||
Net amortization
|
3,654 | 273 | 1,549 | 304 | ||||||||||||
Net periodic benefit cost
|
$ | 5,470 | $ | 1,867 | $ | 2,359 | $ | 1,571 | ||||||||
Other Postretirement Benefits | ||||||||||||||||
Nine Months Ended |
||||||||||||||||
Three Months Ended September 30, | September 30, | |||||||||||||||
2009 | 2008 | 2009 | 2008 | |||||||||||||
(In thousands) | ||||||||||||||||
Service cost
|
$ | 149 | $ | 153 | $ | 441 | $ | 459 | ||||||||
Interest cost
|
343 | 332 | 1,017 | 999 | ||||||||||||
Net amortization
|
23 | 29 | 47 | 99 | ||||||||||||
Net periodic benefit cost
|
$ | 515 | $ | 514 | $ | 1,505 | $ | 1,557 | ||||||||
The Company previously disclosed in its financial statements for
the year ended December 31, 2008, that it expected to
contribute approximately $11.7 million to its defined
benefit plans and $1.3 million to its other postretirement
benefit plans in 2009. As of September 30, 2009,
$9.3 million of contributions have been made to the defined
benefit plans and $0.7 million have been made to its other
postretirement benefit plans. The Company presently anticipates
contributing up to an additional $3.0 million in 2009 to
fund these defined benefit and other postretirement benefit
plans.
14. | Legal Proceedings |
The Company is party to various legal proceedings arising in the
ordinary course of business, none of which are expected to have
a material adverse effect on its business, financial condition,
results of operations or cash flows.
15. | Income Taxes |
The Companys provision for income taxes is based upon
estimated annual tax rates for the year applied to federal,
state and foreign income. The provision for income taxes
increased to $14.2 million in the third quarter of 2009
from $9.8 million in the third quarter of 2008. The
effective tax rate decreased to 32.2% for the third quarter of
2009 compared to 33.0% in the third quarter of 2008 due to the
mix of global pre-tax income among jurisdictions and unfavorable
non-recurring discrete items in the third quarter of 2008.
The Company and its subsidiaries file income tax returns in the
U.S. federal jurisdiction, and various state and foreign
jurisdictions. Due to the potential for resolution of federal,
state and foreign examinations, and the expiration of various
statutes of limitation, it is reasonably possible that the
Companys gross unrecognized tax benefits balance may
change within the next twelve months by a range of zero to
$0.3 million.
18
Table of Contents
IDEX
CORPORATION AND SUBSIDIARIES
NOTES TO
CONDENSED CONSOLIDATED FINANCIAL
STATEMENTS (Continued)
16. | New Accounting Pronouncements |
In October 2009, the FASB issued ASU
No. 2009-13,
Revenue Recognition (Topic 605)
Multiple-Deliverable Revenue Arrangements. ASU
No. 2009-13
addresses the accounting for multiple-deliverable arrangements
to enable vendors to account for products or services
(deliverables) separately rather than as a combined unit. This
guidance establishes a selling price hierarchy for determining
the selling price of a deliverable, which is based on:
(a) vendor-specific objective evidence;
(b) third-party evidence; or (c) estimates. This
guidance also eliminates the residual method of allocation and
requires that arrangement consideration be allocated at the
inception of the arrangement to all deliverables using the
relative selling price method. In addition, this guidance
significantly expands required disclosures related to a
vendors multiple-deliverable revenue arrangements. ASU
No. 2009-13
is effective prospectively for revenue arrangements entered into
or materially modified in fiscal years beginning on or after
June 15, 2010 and early adoption is permitted. A company
may elect, but will not be required, to adopt the amendments in
ASU
No. 2009-13
retrospectively for all prior periods. Management is currently
evaluating the requirements of ASU
No. 2009-13
and has not yet determined the impact on the Companys
condensed consolidated financial statements.
In August 2009, the FASB issued ASU
2009-05,
Fair Value Measurements and Disclosures (Topic
820) Measuring Liabilities at Fair Value
(Update
2009-05).
2009-05
provides clarification regarding valuation techniques when a
quoted price in an active market for an identical liability is
not available in addition to treatment of the existence of
restrictions that prevent the transfer of a liability.
2009-05 also
clarifies that both a quoted price in an active market for an
identical liability at the measurement date and the quoted price
for an identical liability when traded as an asset in an active
market (when no adjustments to the quoted price of the asset are
required) are Level 1 fair value measurements. This
standard is effective for the first reporting period, including
interim periods, beginning after issuance. Adoption of
2009-05 did
not have a material effect on the consolidated financial
position, results of operations or cash flows of the Company.
In December 2008, the FASB issued ASC 715
Compensation-Retirement Benefits. This standard
provides additional guidance on employers disclosures
about the plan assets of defined benefit pension or other
postretirement plans. ASC 715 requires disclosures about how
investment allocation decisions are made, the fair value of each
major category of plan assets, valuation techniques used to
develop fair value measurements of plan assets, the impact of
measurements on changes in plan assets when using significant
unobservable inputs and significant concentrations of risk in
the plan assets. These disclosures are required for fiscal years
ending after December 15, 2009. The Company is currently
assessing the impact of this standard on its financial statement
disclosures.
19
Table of Contents
Item 2. | Managements Discussion and Analysis of Financial Condition and Results of Operations. |
Cautionary
Statement Under the Private Securities Litigation Reform
Act
The Historical Overview and the Liquidity and
Capital Resources sections of this managements
discussion and analysis of our financial condition and results
of operations contain forward-looking statements within the
meaning of Section 27A of the Securities Act of 1933, as
amended, and Section 21E of the Exchange Act of 1934, as
amended. These statements may relate to, among other things,
operating results and are indicated by words or phrases such as
expects, should, will, and
similar words or phrases. These statements are subject to
inherent uncertainties and risks that could cause actual results
to differ materially from those anticipated at the date of this
filing. The risks and uncertainties include, but are not limited
to, IDEX Corporations (IDEX or the
Company) ability to integrate and operate acquired
businesses on a profitable basis and other risks and
uncertainties identified under the heading Risk
Factors included in item 1A of the Companys
Annual Report on
Form 10-K
for the year ended December 31, 2008 and information
contained in subsequent periodic reports filed by IDEX with the
Securities and Exchange Commission. Investors are cautioned not
to rely unduly on forward-looking statements when evaluating the
information presented here.
Historical
Overview
IDEX is an applied solutions company specializing in fluid and
metering technologies, health and science technologies,
dispensing equipment, and fire, safety and other diversified
products built to its customers specifications. Our
products are sold in niche markets to a wide range of industries
throughout the world. Accordingly, our businesses are affected
by levels of industrial activity and economic conditions in the
U.S. and in other countries where we do business and by the
relationship of the U.S. dollar to other currencies. Levels
of capacity utilization and capital spending in certain
industries and overall industrial activity are among the factors
that influence the demand for our products.
IDEX consists of four reportable
segments: Fluid & Metering Technologies,
Health & Science Technologies, Dispensing Equipment
and Fire & Safety/Diversified Products.
The Fluid & Metering Technologies Segment produces
pumps, compressors, flow meters and related controls for the
movement of liquids and gases in a diverse range of end markets
from industrial infrastructure to food and beverage; and
provides metering technology and flow monitoring services for
water and wastewater markets. The Health & Science
Technologies Segment produces a wide variety of small scale,
highly accurate pumps, valves, fittings and medical devices, as
well as compressors used in medical, dental and industrial
applications. The Dispensing Equipment Segment produces highly
engineered equipment for dispensing, metering and mixing
colorants, paints, inks and dyes, hair colorants and other
personal care products, refinishing equipment, as well as the
food industry. The Fire & Safety/Diversified Products
Segment produces firefighting pumps, rescue tools, lifting bags
and other components and systems for the fire and rescue
industry; and engineered stainless steel banding and clamping
devices used in a variety of industrial and commercial
applications.
Results
of Operations
On July 1, 2009 FASB ASC became the authoritative source of
accounting principals to be applied to financial statements
prepared in accordance with U.S. GAAP. In accordance with
the ASC, citations to accounting literature in this report are
to the relevant topic of the ASC or are presented in plain
English.
The following is a discussion and analysis of our financial
position and results of operations for the period ended
September 30, 2009 and 2008. For purposes of this
discussion and analysis section, reference is made to the table
below and the Companys Condensed Consolidated Statements
of Operations included in Item 1. As of January 1,
2009, we changed our method of accounting for inventory from the
LIFO method to the FIFO method. Certain prior year amounts have
been restated to reflect the LIFO to FIFO inventory costing
change (see Note 5).
Performance
in the Three Months Ended September 30, 2009 Compared with
the Same Period of 2008
Sales in the three months ended September 30, 2009 were
$323.2 million, a 12% decrease from the comparable period
last year. This decrease reflects a 17% decrease in organic
sales and 2% unfavorable foreign currency
20
Table of Contents
translation, partially offset by a 7% increase from four
acquisitions (Richter October 2008, iPEK
October 2008, IETG October 2008 and
Semrock October 2008). Sales to international
customers represented approximately 48% of total sales in the
current period compared to 46% in the same period in 2008.
For the third quarter of 2009, Fluid & Metering
Technologies contributed 48 percent of sales and
46 percent of operating income; Health & Science
Technologies accounted for 24 percent of sales and
26 percent of operating income; Dispensing Equipment
accounted for 8 percent of sales and 0 percent of
operating income; and Fire & Safety/Diversified
Products represented 20 percent of sales and
28 percent of operating income.
Fluid & Metering Technologies sales of
$156.9 million for the three months ended
September 30, 2009 declined $13.3 million, or 8%
compared with 2008, reflecting a 19% decrease in organic growth
and 1% unfavorable foreign currency translation, partially
offset by a 12% increase for acquisitions (Richter, iPEK and
IETG). The decrease in organic growth was driven by weakness in
chemical, energy, water and waste water markets. In the third
quarter of 2009, organic sales decreased approximately 23%
domestically and 11% internationally. Organic business sales to
customers outside the U.S. were approximately 41% of total
segment sales during the third quarter of 2009 and 40% in 2008.
Health & Science Technologies sales of
$76.1 million decreased $6.8 million, or 8% in the
third quarter of 2009 compared with 2008. This reflects a 13%
decrease in organic growth and 1% of unfavorable foreign
currency translation, partially offset by a 6% increase from the
acquisition of Semrock. The decrease in organic growth reflects
market softness in non-core Health & Science
Technologies businesses. In the third quarter of 2009, organic
sales decreased 24% domestically and increased 4%
internationally. Organic business sales to customers outside the
U.S. were approximately 46% of total segment sales in the
third quarter of 2009, compared to 38% in 2008.
Dispensing Equipment sales of $25.6 million decreased
$6.0 million, or 19% in the third quarter of 2009 compared
with 2008. This decrease reflects a 15% decrease in organic
growth and 4% of unfavorable foreign currency translation. The
decrease in organic growth was due to continued deterioration in
capital spending in the European and North American markets. In
the third quarter of 2009, organic sales decreased 29%
domestically and 10% internationally. Organic sales to customers
outside the U.S. were approximately 78% of total segment
sales in the third quarter of 2009, compared with 72% in the
comparable quarter of 2008.
Fire & Safety/Diversified Products sales of
$65.5 million decreased $15.7 million, or 19% in the
third quarter of 2009 compared with 2008. This change reflects a
16% decrease in organic business volume and 3% unfavorable
foreign currency translation. The decrease in organic business
growth was driven by lower demand for engineered band clamping
systems and rescue equipment. In the third quarter of 2009,
organic business sales decreased 12% domestically and 20%
internationally. Organic sales to customers outside the
U.S. were approximately 55% of total segment sales in the
third quarter of 2009, compared to 56% in 2008.
21
Table of Contents
Three Months |
Nine Months |
|||||||||||||||
Ended September 30, | Ended September 30, | |||||||||||||||
2009(1) | 2008(2) | 2009(1) | 2008(2) | |||||||||||||
Fluid & Metering Technologies
|
||||||||||||||||
Net sales
|
$ | 156,939 | $ | 170,258 | $ | 470,957 | $ | 518,546 | ||||||||
Operating
income(3)
|
25,755 | 33,656 | 70,731 | 98,227 | ||||||||||||
Operating margin
|
16.4 | % | 19.8 | % | 15.0 | % | 18.9 | % | ||||||||
Depreciation and amortization
|
$ | 8,061 | $ | 5,842 | $ | 24,396 | $ | 18,605 | ||||||||
Capital expenditures
|
3,810 | 2,519 | 9,682 | 7,695 | ||||||||||||
Health & Science Technologies
|
||||||||||||||||
Net sales
|
$ | 76,138 | $ | 82,889 | $ | 224,142 | $ | 253,778 | ||||||||
Operating
income(3)
|
14,287 | 17,012 | 34,703 | 47,896 | ||||||||||||
Operating margin
|
18.8 | % | 20.5 | % | 15.5 | % | 18.9 | % | ||||||||
Depreciation and amortization
|
$ | 3,866 | $ | 2,573 | $ | 10,579 | $ | 8,411 | ||||||||
Capital expenditures
|
1,879 | 1,294 | 3,793 | 3,894 | ||||||||||||
Dispensing Equipment
|
||||||||||||||||
Net sales
|
$ | 25,580 | $ | 31,543 | $ | 104,111 | $ | 138,152 | ||||||||
Operating income (loss)
(3)(5)
|
(311 | ) | (32,026 | ) | 13,112 | (6,526 | ) | |||||||||
Operating
margin(5)
|
(1.2 | )% | (101.5 | )% | 12.6 | % | (4.7 | )% | ||||||||
Depreciation and amortization
|
$ | 670 | $ | 946 | $ | 2,340 | $ | 3,215 | ||||||||
Capital expenditures
|
292 | 652 | 850 | 2,236 | ||||||||||||
Fire & Safety/Diversified Products
|
||||||||||||||||
Net sales
|
$ | 65,524 | $ | 81,189 | $ | 192,633 | $ | 227,099 | ||||||||
Operating
income(3)
|
15,932 | 20,401 | 42,790 | 56,959 | ||||||||||||
Operating margin
|
24.3 | % | 25.1 | % | 22.2 | % | 25.1 | % | ||||||||
Depreciation and amortization
|
$ | 1,287 | $ | 1,206 | $ | 3,815 | $ | 3,950 | ||||||||
Capital expenditures
|
853 | 789 | 2,569 | 3,929 | ||||||||||||
Company
|
||||||||||||||||
Net sales
|
$ | 323,249 | $ | 365,193 | $ | 986,317 | $ | 1,134,165 | ||||||||
Operating
income(3)
|
46,517 | 30,804 | 132,413 | 168,326 | ||||||||||||
Operating margin
|
14.4 | % | 8.4 | % | 13.4 | % | 14.8 | % | ||||||||
Depreciation and
amortization(4)
|
$ | 14,135 | $ | 10,879 | $ | 41,893 | $ | 35,092 | ||||||||
Capital expenditures
|
7,081 | 5,851 | 18,303 | 19,164 |
(1) | Data includes acquisition of Richter (October 2008), iPEK (October 2008) and IETG (October 2008) in the Fluid & Metering Technologies segment and Semrock (October 2008) in the Health & Science Technologies segment from the dates of acquisition. | |
(2) | Certain prior year amounts have been restated to reflect the LIFO to FIFO inventory costing change. | |
(3) | Group operating income excludes unallocated corporate operating expenses. | |
(4) | Excludes amortization of debt issuance expenses. | |
(5) | Segment operating income and margin includes $30.1 million goodwill impairment charge in 2008 for Fluid Management Americas. |
Gross profit of $129.1 million in the third quarter of 2009
decreased $18.7 million, or 13% from 2008. Gross profit as
a percent of sales was 39.9% in the third quarter of 2009 and
40.5% in 2008. The decrease in gross margin primarily reflects
product mix as well as the impact of fixed cost expense from
lower volume across most of our businesses.
22
Table of Contents
Selling, general and administrative (SG&A)
expenses decreased to $79.8 million in the third quarter of
2009 from $81.6 million in 2008. The $1.8 million
decrease reflects approximately $9.3 million for volume
related expenses, partially offset by a $7.5 million
increase for incremental costs associated with recently acquired
businesses. As a percent of sales, SG&A expenses were 24.7%
for 2009 and 22.3% for 2008.
During the three months ended September 30, 2009 and 2008,
the Company recorded pre-tax restructuring expenses totaling
$2.8 million and $5.3 million, respectively, for
employee severance related to employee reductions across various
functional areas and facility closures resulting from the
Companys cost savings initiatives.
During the three months ended September 30, 2008 in
accordance with ASC 350, the Company concluded that events had
occurred and circumstances had changed which required the
Company to perform an interim period goodwill impairment test at
Fluid Management Americas, a reporting unit within the
Companys Dispensing Equipment Segment. Fluid Management
Americas had experienced a downturn in capital spending by its
customer base and the loss of a major retail customer. The
Company performed an impairment test and compared the fair value
of the reporting unit to its carrying value. It was determined
that the fair value of Fluid Management Americas was less than
the carrying value of the net assets. The excess of the fair
value of the reporting unit over the amounts assigned to its
assets and liabilities is the implied fair value of goodwill.
The Companys analysis resulted in an implied fair value of
goodwill of $21.2 million, and as a result, the Company
recognized an impairment charge of $30.1 million in the
third quarter of 2008.
Operating income of $46.5 million and operating margins of
14.4% in the third quarter of 2009 were up from the
$30.8 million and 8.4% recorded in 2008, primarily
reflecting decreased expenses from previously announced
restructuring-related charges and the goodwill impairment charge
in 2008, partially offset by decreased volume. In the
Fluid & Metering Technologies Segment, operating
income of $25.8 million and operating margins of 16.4% in
the third quarter of 2009 were down from the $33.7 million
and 19.8% recorded in 2008 principally due to the impact of
recent acquisitions and lower sales. In the Health &
Science Technologies Segment, operating income of
$14.3 million and operating margins of 18.8% in the third
quarter of 2009 were down from the $17.0 million and 20.5%
recorded in 2008 due to lower volume. In the Dispensing
Equipment Segment, operating loss of $0.3 million and
operating margins of (1.2)% in the third quarter of 2009 were up
from the $32.0 million operating loss in 2008, due
primarily to goodwill impairment charges in 2008, partially
offset by lower volumes in the North American and European
markets. Operating income and operating margins in the
Fire & Safety/Diversified Products Segment of
$15.9 million and 24.3%, respectively, were lower than the
$20.4 million and 25.1% recorded in 2008, due primarily to
lower volume and unfavorable product mix.
The provision for income taxes is based upon estimated annual
tax rates for the year applied to federal, state and foreign
income. The provision for income taxes increased to
$14.2 million in the third quarter of 2009 compared to the
third quarter of 2008, which was $9.8 million. The
effective tax rate decreased to 32.2% for the third quarter of
2009 compared to 33.0% in the third quarter of 2008 due to the
mix of global pre-tax income among jurisdictions.
Net income for the current quarter of $29.8 million
increased from the $19.9 million earned in the third
quarter of 2008. Diluted earnings per share in the third quarter
of 2009 of $0.37 increased $0.13, or 54%, compared with the
third quarter of 2008.
Performance
in the Nine Months Ended September 30, 2009 Compared with
the Same Period of 2008
Sales in the nine months ended September 30, 2009 were
$986.3 million, a 13% decrease from the comparable period
last year. This decrease reflects a 16% decrease in organic
sales and 3% unfavorable foreign currency translation, partially
offset by a 6% increase from four acquisitions
(Richter October 2008, iPEK October
2008, IETG October 2008 and Semrock
October 2008). Sales to international customers represented
approximately 46% of total sales in the current period compared
to 47% in the same period in 2008.
For the first nine months of 2009, Fluid & Metering
Technologies contributed 48 percent of sales and
44 percent of operating income; Health & Science
Technologies accounted for 23 percent of sales and
22 percent of operating income; Dispensing Equipment
accounted for 10 percent of sales and 8 percent of
operating income; and Fire & Safety/Diversified
Products represented 19 percent of sales and
26 percent of operating income.
23
Table of Contents
Fluid & Metering Technologies sales of
$471.0 million for the nine months ended September 30,
2009 declined $47.6 million, or 9% compared with 2008,
reflecting a 19% decrease in organic growth and 2% unfavorable
foreign currency translation, partially offset by a 12% increase
for acquisitions (Richter, iPEK and IETG). The decrease in
organic growth was driven by weakness in chemical, energy, water
and waste water markets. In the first nine months of 2009,
organic sales decreased approximately 19% domestically and 17%
internationally. Organic business sales to customers outside the
U.S. were approximately 40% of total segment sales during
the first nine months of 2009, compared to 42% in 2008.
Health & Science Technologies sales of
$224.1 million decreased $29.6 million, or 12% in the
first nine months of 2009 compared with 2008. This reflects a
16% decrease in organic growth and 2% of unfavorable foreign
currency translation, partially offset by a 6% increase from the
acquisition of Semrock. The organic decline reflects significant
market softness in non-core Health & Science
Technologies businesses. In the first nine months of 2009,
organic sales decreased 16% domestically and 15%
internationally. Organic business sales to customers outside the
U.S. were approximately 40% of total segment sales in the
first nine months of 2009, compared to 39% in 2008.
Dispensing Equipment sales of $104.1 million decreased
$34.0 million, or 25% in the first nine months of 2009
compared with 2008. This decrease reflects a 19% decrease in
organic growth and 6% of unfavorable foreign currency
translation. The decrease in organic growth was due to continued
deterioration in capital spending in the European and North
American markets, partially offset by one large replenishment
project in the North American market. In the first nine months
of 2009, organic sales increased 13% domestically and decreased
30% internationally. Organic sales to customers outside the
U.S. were approximately 64% of total segment sales in the
first nine months of 2009, compared with 72% in the comparable
period of 2008.
Fire & Safety/Diversified Products sales of
$192.6 million decreased $34.5 million, or 15% in the
first nine months of 2009 compared with 2008. This change
reflects a 9% decrease in organic business volume and 6%
unfavorable foreign currency translation. The decrease in
organic business growth was driven by lower demand for
engineered band clamping systems and rescue equipment. In the
first nine months of 2009, organic business sales decreased 11%
domestically and 8% internationally. Organic sales to customers
outside the U.S. were approximately 55% of total segment
sales in the first nine months of 2009, compared to 56% in 2008.
Gross profit of $383.4 million in the first nine months of
2009 decreased $78.4 million, or 17% from 2008. Gross
profit as a percent of sales was 38.9% in the first nine months
of 2009 and 40.7% in 2008. The decrease in gross margin
primarily reflects product mix, inventory fair value expense as
well as the impact of fixed cost absorption from lower volume
across most of our businesses.
SG&A expenses decreased to $242.7 million in the first
nine months of 2009 from $258.1 million in 2008. The
$15.4 million decrease reflects approximately
$37.2 million for volume related expenses, partially offset
by a $21.8 million increase for incremental costs
associated with recently acquired businesses. As a percent of
sales, SG&A expenses were 24.6% for 2009 and 22.8% for 2008.
During the nine months ended September 30, 2009 and 2008,
the Company recorded pre-tax restructuring expenses totaling
$8.3 million and $5.3 million, respectively, for
employee severance related to employee reductions across various
functional areas and facility closures resulting from the
Companys cost savings initiatives.
During the first nine months of 2008 in accordance with ASC 350,
the Company concluded that events had occurred and circumstances
had changed which required the Company to perform an interim
period goodwill impairment test at Fluid Management Americas, a
reporting unit within the Companys Dispensing Equipment
Segment. Fluid Management Americas had experienced a downturn in
capital spending by its customer base and the loss of a major
retail customer. The Company performed an impairment test and
compared the fair value of the reporting unit to its carrying
value. It was determined that the fair value of Fluid Management
Americas was less than the carrying value of the net assets. The
excess of the fair value of the reporting unit over the amounts
assigned to its assets and liabilities is the implied fair value
of goodwill. The Companys analysis resulted in an implied
fair value of goodwill of $21.2 million, and as a result,
the Company recognized an impairment charge of
$30.1 million in the first nine months of 2008.
24
Table of Contents
Operating income of $132.4 million and operating margins of
13.4% in the first nine months of 2009 were down from the
$168.3 million and 14.8% recorded in 2008, primarily
reflecting increased expenses from previously announced
restructuring-related charges, impact from acquisitions and a
decrease in volume, partially offset by the goodwill impairment
charge in 2008. In the Fluid & Metering Technologies
Segment, operating income of $70.7 million and operating
margins of 15.0% in the first nine months of 2009 were down from
the $98.2 million and 18.9% recorded in 2008 principally
due to the impact of recent acquisitions and lower sales. In the
Health & Science Technologies Segment, operating
income of $34.7 million and operating margins of 15.5% in
the first nine months of 2009 were down from the
$47.9 million and 18.9% recorded in 2008 due to lower
volume. In the Dispensing Equipment Segment, operating income of
$13.1 million and operating margins of 12.6% in the first
nine months of 2009 were up from the $6.5 million of
operating loss and recorded in 2008, due to a goodwill
impairment charge in 2008, partially offset by continued
deterioration in the North American and European markets.
Operating income and operating margins in the Fire &
Safety/Diversified Products Segment of $42.8 million and
22.2%, respectively, were lower than the $57.0 million and
25.1% recorded in 2008, due primarily to lower volume and
unfavorable product mix.
The provision for income taxes is based upon estimated annual
tax rates for the year applied to federal, state and foreign
income. The provision for income taxes decreased to
$39.7 million in the first nine months of 2009 compared to
the same period of 2008, which was $54.0 million. The
effective tax rate of 33.1% in the first nine months of 2009 was
lower compared to 34.1% in the same period of 2008 due to the
mix of global pre-tax income among jurisdictions.
Net income for the current period of $80.3 million
decreased from the $104.5 million earned in the first nine
months of 2008. Diluted earnings per share in the first nine
months of 2009 of $0.99 decreased $0.27, or 21%, compared with
the first nine months of 2008.
Liquidity
and Capital Resources
At September 30, 2009, working capital was
$251.7 million and our current ratio was 2.2 to 1. Cash
flows from operating activities decreased $10.4 million, or
6%, to $157.7 million in the first nine months of 2009
mainly due to reduced volume and restructuring-related payments.
Cash flows provided by operations were more than adequate to
fund capital expenditures of $18.3 million and
$19.1 million in the first nine months of 2009 and 2008,
respectively. Capital expenditures were generally for machinery
and equipment that improved productivity and tooling to support
the global sourcing initiatives, although a portion was for
business system technology and replacement of equipment and
facilities. Management believes that the Company has ample
capacity in its plants and equipment to meet expected needs for
future growth in the intermediate term.
The Company maintains a $600.0 million unsecured domestic,
multi-currency bank revolving credit facility, which expires on
December 21, 2011. At September 30, 2009 there was
$347.7 million outstanding under the Credit Facility and
outstanding letters of credit totaled approximately
$7.1 million. The net available borrowing under the Credit
Facility as of September 30, 2009, was approximately
$245.2 million. Interest is payable quarterly on the
outstanding borrowings at the bank agents reference rate.
Interest on borrowings based on LIBOR plus an applicable margin
is payable on the maturity date of the borrowing, or quarterly
from the effective date for borrowings exceeding three months.
The applicable margin is based on the Companys senior,
unsecured, long-term debt rating and can range from
24 basis points to 50 basis points. Based on the
Companys BBB rating at September 30, 2009, the
applicable margin was 40 basis points. An annual Credit
Facility fee, also based on the Companys credit rating, is
currently 10 basis points and is payable quarterly.
At September 30, 2009 the Company has one interest rate
exchange agreement related to the Credit Facility. The interest
rate exchange agreement, expiring in January 2011, effectively
converted $250.0 million of floating-rate debt into
fixed-rate debt at an interest rate of 3.25%. The fixed rate
noted above is comprised of the fixed rate on the interest rate
exchange agreement and the Companys current margin of
40 basis points on the Credit Facility.
On April 18, 2008, the Company completed a
$100.0 million unsecured senior bank term loan agreement,
with covenants consistent with the existing Credit Facility and
a maturity on December 21, 2011. At September 30,
2009,
25
Table of Contents
there was $95.0 million outstanding under the Term Loan
with $5.0 million included within short term borrowings.
Interest under the Term Loan is based on the bank agents
reference rate or LIBOR plus an applicable margin and is payable
at the end of the selected interest period, but at least
quarterly. The applicable margin is based on the Companys
senior, unsecured, long-term debt rating and can range from 45
to 100 basis points. Based on the Companys current
debt rating, the applicable margin is 80 basis points. The
Term Loan requires repayments of $5.0 million and
$7.5 million in April of 2010 and 2011, respectively, with
the remaining balance due on December 21, 2011. The Company
used the proceeds from the Term Loan to pay down existing debt
outstanding under the Credit Facility. At September 30,
2009 the Company has an interest rate exchange agreement related
to the Term Loan that expires December 2011. With a current
notional amount of $95.0 million, the agreement effectively
converted $100.0 million of floating-rate debt into
fixed-rate debt at an interest rate of 4.00%. The fixed rate is
comprised of the fixed rate on the interest rate exchange
agreement and the Companys current margin of 80 basis
points on the Term Loan.
On April 21, 2008, the Companys Board of Directors
authorized the repurchase of up to $125.0 million of its
outstanding common shares. Repurchases under the new program
will be funded with cash flow generation, and made from time to
time in either the open market or through private transactions.
The timing, volume, and nature of share repurchases will be at
the discretion of management, dependent on market conditions,
other priorities for cash investment, applicable securities
laws, and other factors, and may be suspended or discontinued at
any time. Since inception of the repurchase program,
2.3 million shares have been purchased at a cost of
$50.0 million; no shares have been purchased during the
first nine months of 2009.
Despite the current downturn in global financial markets, the
Company has not experienced any liquidity issues and we continue
to expect that our current liquidity, notwithstanding these
adverse market conditions, will be sufficient to meet our
operating requirements, interest on all borrowings, required
debt repayments, any authorized share repurchases, planned
capital expenditures, and annual dividend payments to holders of
common stock during the next twelve months. In the event that
suitable businesses are available for acquisition upon terms
acceptable to the Board of Directors, we may obtain all or a
portion of the financing for the acquisitions through the
incurrence of additional long-term borrowings. However, in light
of recent adverse events in global financial and economic
conditions, we cannot be certain that additional financing will
be available on satisfactory terms, if at all.
Item 3. | Quantitative and Qualitative Disclosures About Market Risk. |
The Company is subject to market risk associated with changes in
foreign currency exchange rates and interest rates. We may, from
time to time, enter into foreign currency forward contracts and
interest rate exchange agreements on our debt when we believe
there is a financial advantage in doing so. A treasury risk
management policy, adopted by the Board of Directors, describes
the procedures and controls over derivative financial and
commodity instruments, including foreign currency forward
contracts and interest rate swaps. Under the policy, we do not
use derivative financial or commodity instruments for trading
purposes, and the use of these instruments is subject to strict
approvals by senior officers. Typically, the use of derivative
instruments is limited to foreign currency forward contracts and
interest rate exchange agreements on the Companys
outstanding long-term debt. The Companys exposure related
to derivative instruments is, in the aggregate, not material to
its financial position, results of operations or cash flows.
The Companys foreign currency exchange rate risk is
limited principally to the Euro, British Pound, Canadian Dollar
and Chinese Renminbi. We manage our foreign exchange risk
principally through invoicing our customers in the same currency
as the source of our products. The effect of transaction gains
and losses is reported within Other income
(expense)-net on the Condensed Consolidated Statements of
Operations. At September 30, 2009 the Company had foreign
currency contracts with an aggregate notional amount of
$3.4 million.
The Companys interest rate exposure is primarily related
to the $447.1 million of total debt outstanding at
September 30, 2009. The majority of the debt is priced at
interest rates that float with the market. In order to mitigate
this interest exposure, the Company entered into interest rate
exchange agreements that effectively converted
$345.0 million of our floating-rate debt outstanding at
September 30, 2009 to a fixed-rate. A 50-basis point
movement in the interest rate on the remaining
$102.1 million floating-rate debt would result in an
approximate $0.5 million annualized increase or decrease in
interest expense and cash flows.
26
Table of Contents
Item 4. | Controls and Procedures. |
The Company maintains disclosure controls and procedures that
are designed to ensure that information required to be disclosed
in the Companys Exchange Act reports is recorded,
processed, summarized and reported within the time periods
specified in the SECs rules and forms, and that such
information is accumulated and communicated to the
Companys management, including its Chief Executive Officer
and Chief Financial Officer, as appropriate, to allow timely
decisions regarding required disclosure. In designing and
evaluating the disclosure controls and procedures, management
recognized that any controls and procedures, no matter how well
designed and operated, can provide only reasonable assurance of
achieving the desired control objectives, and management is
required to apply its judgment in evaluating the cost-benefit
relationship of possible controls and procedures.
As required by SEC
Rule 13a-15(b),
the Company carried out an evaluation, under the supervision and
with the participation of the Companys management,
including the Companys Chief Executive Officer and the
Companys Chief Financial Officer, of the effectiveness of
the design and operation of the Companys disclosure
controls and procedures as of the end of the period covered by
this report. Based on the foregoing, the Companys Chief
Executive Officer and Chief Financial Officer concluded that the
Companys disclosure controls and procedures were effective.
There has been no change in the Companys internal controls
over financial reporting during the Companys most recent
fiscal quarter that has materially affected, or is reasonably
likely to materially affect, the Companys internal
controls over financial reporting.
27
Table of Contents
PART II.
OTHER INFORMATION
Item 1. | Legal Proceedings. |
The Company and six of its subsidiaries are presently named as
defendants in a number of lawsuits claiming various
asbestos-related personal injuries, allegedly as a result of
exposure to products manufactured with components that contained
asbestos. Such components were acquired from third party
suppliers, and were not manufactured by any of the subsidiaries.
To date, the majority of the Companys settlements and
legal costs, except for costs of coordination, administration,
insurance investigation and a portion of defense costs, have
been covered in full by insurance subject to applicable
deductibles. However, the Company cannot predict whether and to
what extent insurance will be available to continue to cover
such settlements and legal costs, or how insurers may respond to
claims that are tendered to them.
Claims have been filed in jurisdictions throughout the United
States. Most of the claims resolved to date have been dismissed
without payment. The balance have been settled for various
insignificant amounts. Only one case has been tried, resulting
in a verdict for the Companys business unit.
No provision has been made in the financial statements of the
Company, other than for insurance deductibles in the ordinary
course, and the Company does not currently believe the
asbestos-related claims will have a material adverse effect on
the Companys business, financial position, results of
operations or cash flow.
The Company is also party to various other legal proceedings
arising in the ordinary course of business, none of which is
expected to have a material adverse effect on its business,
financial condition, results of operations or cash flow.
Item 2. | Unregistered Sales of Equity Securities and Use of Proceeds. |
Total Number of |
Maximum Dollar |
|||||||||||||||
Shares Purchased as |
Value that May Yet |
|||||||||||||||
Part of Publicly |
be Purchased |
|||||||||||||||
Total Number of |
Average Price |
Announced Plans |
Under the Plans |
|||||||||||||
Period
|
Shares Purchased | Paid per Share | or Programs(1) | or Programs(1) | ||||||||||||
July 1, 2009 to
|
||||||||||||||||
July 31, 2009
|
| | | $ | 75,000,020 | |||||||||||
August 1, 2009 to
|
||||||||||||||||
August 31, 2009
|
| | | $ | 75,000,020 | |||||||||||
September 1, 2009 to
|
||||||||||||||||
September 30, 2009
|
| | | $ | 75,000,020 | |||||||||||
Total
|
| | | $ | 75,000,020 | |||||||||||
(1) | On April 21, 2008, IDEXs Board of Directors authorized the repurchase of up to $125.0 million of its outstanding common shares either in the open market or through private transactions. |
Item 5. | Other Information. |
There has been no material change to the procedures by which
security holders may recommend nominees to the Companys
board.
Item 6. | Exhibits. |
The exhibits listed in the accompanying
Exhibit Index are filed as part of this report.
28
Table of Contents
Table of Contents
EXHIBIT INDEX
Exhibit |
||||
Number
|
Description
|
|||
3 | .1 | Restated Certificate of Incorporation of IDEX Corporation (formerly HI, Inc.) (incorporated by reference to Exhibit No. 3.1 to the Registration Statement on Form S-1 of IDEX, et al., Registration No. 33-21205, as filed on April 21, 1988) | ||
3 | .1(a) | Amendment to Restated Certificate of Incorporation of IDEX Corporation (formerly HI, Inc.), (incorporated by reference to Exhibit No. 3.1(a) to the Quarterly Report of IDEX on Form 10-Q for the quarter ended March 31, 1996, Commission File No. 1-10235) | ||
3 | .1(b) | Amendment to Restated Certificate of Incorporation of IDEX Corporation (incorporated by reference to Exhibit No. 3.1(b) to the Current Report of IDEX on Form 8-K dated March 24, 2005, Commission File No. 1-10235) | ||
3 | .2 | Amended and Restated By-Laws of IDEX Corporation (incorporated by reference to Exhibit No. 3.2 to Post-Effective Amendment No. 2 to the Registration Statement on Form S-1 of IDEX, et al., Registration No. 33-21205, as filed on July 17, 1989) | ||
3 | .2(a) | Amended and Restated Article III, Section 13 of the Amended and Restated By-Laws of IDEX Corporation (incorporated by reference to Exhibit No. 3.2(a) to Post-Effective Amendment No. 3 to the Registration Statement on Form S-1 of IDEX, et al., Registration No. 33-21205, as filed on February 12, 1990) | ||
4 | .1 | Restated Certificate of Incorporation and By-Laws of IDEX Corporation (filed as Exhibits No. 3.1 through 3.2(a)) | ||
4 | .2 | Specimen Certificate of Common Stock of IDEX Corporation (incorporated by reference to Exhibit No. 4.3 to the Registration Statement on Form S-2 of IDEX, et al., Registration No. 33-42208, as filed on September 16, 1991) | ||
4 | .3 | Credit Agreement, dated as of December 21, 2006, among IDEX Corporation, Bank of America N.A. as Agent and Issuing Bank, and the other financial institutions party hereto (incorporated by reference to Exhibit No. 10.1 to the Current Report of IDEX on Form 8-K dated December 22, 2006, Commission File No. 1-10235) | ||
4 | .3(a) | Amendment No. 2 to Credit Agreement, dated as of September 29, 2008, among IDEX Corporation, Bank of America N.A. as Agent and Issuing Bank, and the other financial institutions party hereto (incorporated by reference to Exhibit No. 4.3(a) to the Quarterly Report of IDEX on Form 10-Q for the quarter ended September 30, 2008, Commission File No. 1-10235) | ||
4 | .4 | Term Loan Agreement, dated April 18, 2008, among IDEX Corporation, Bank of America N.A. as Agent, and the other financial institutions party hereto (incorporated by reference to Exhibit No. 10.1 to the Current Report of IDEX on Form 8-K dated April 18, 2008, Commission File No. 1-10235) | ||
18 | Letter from Deloitte and Touche, LLP regarding change in accounting principle hereto (incorporated by reference to Exhibit No. 18 to the Quarterly Report of IDEX on Form 10-Q for the quarter ended March 31, 2009, Commission File No. 1-10235) | |||
*31 | .1 | Certification of Chief Executive Officer Pursuant to Rule 13a-14(a) or Rule 15d-14(a) | ||
*31 | .2 | Certification of Chief Financial Officer Pursuant to Rule 13a-14(a) or Rule 15d-14(a) | ||
*32 | .1 | Certification pursuant to Section 1350 of Chapter 63 of Title 18 of the United States Code | ||
*32 | .2 | Certification pursuant to Section 1350 of Chapter 63 of Title 18 of the United States Code |
* | Filed herewith |
30